Aytu BioPharma (AYTU)
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers presc...
- Open
- 2.150
- High
- 2.150
- Low
- 2.040
- Prev. Close
- 2.140
- Volume
- 29.93K
- Turnover
- 63.13K
- Avg Price
- 2.110
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 5.14%
- 52wk High
- 3.065
- Volume Ratio
- 1.68
- Turnover Ratio
- 0.39%
- 52wk Low
- 1.800
- Float Mkt Cap
- 16.07M
- Market CapUSD
- 22.71M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.31
- EPSDynamic
- -1.31
- EPSStatic
- --
- BVPS
- 3.25
- P/B
- 0.64
- Circulating Supply
- 7.69M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 10.87M
- Min lot size
- 1
- Currency
- USD
Aytu BioPharma Analyst Rating
View moreForecast & Rating
Sep 30, 2026Price forecast
$9.67362.52%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 1 day ago, 12:22 PM
Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
- TradingView · 1 day ago, 09:56 AM
Ascendiant Capital maintains Buy rating on Aytu BioPharma, $15 price target
- Weekly Review · Sep 26 at 06:06 AM
Weekly Recap | Aytu BioPharma +7.55%, earnings beat estimates
- TradingKey · Sep 22 at 11:43 PM
Aytu BioPharma (AYTU) Fiscal Q4 2026 Earnings Call: EXXUA Growth and FY2027 Outlook
- TradingKey · Sep 22 at 09:11 PM
Aytu Fiscal Q4 2026 Earnings: EXXUA Drives Revenue Growth
